Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
Back to Search Results

Connection

Search Results to Jennifer Michelle Trujillo

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Trujillo, Jennifer

Item TypeName
Academic Article GLP-1 receptor agonists for type 2 diabetes mellitus: recent developments and emerging agents.
Academic Article Albiglutide: a new GLP-1 receptor agonist for the treatment of type 2 diabetes.
Academic Article GLP-1 receptor agonists: a review of head-to-head clinical studies.
Academic Article Dulaglutide: the newest GLP-1 receptor agonist for the management of type 2 diabetes.
Academic Article Basal Insulin Use With GLP-1 Receptor Agonists.
Academic Article Lixisenatide, a Once-Daily Prandial Glucagon-Like Peptide-1 Receptor Agonist for the Treatment of Adults with Type 2 Diabetes.
Academic Article iGlarLixi: A Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide for the Treatment of Type 2 Diabetes.
Academic Article A review of the new GLP-1 receptor agonist/basal insulin fixed-ratio combination products.
Academic Article Anticipatory guidance in type 2 diabetes to improve disease management; next steps after basal insulin.
Academic Article Comparison of Usability, Accuracy, Preference, and Satisfaction Among Three Once-Weekly GLP-1 Receptor Agonist Pen Devices.
Concept Glucagon-Like Peptide-1 Receptor
Academic Article Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline.
Academic Article Safety and tolerability of once-weekly GLP-1 receptor agonists in type 2 diabetes.
Academic Article GLP-1 receptor agonists: an updated review of head-to-head clinical studies.
Academic Article Tirzepatide: A novel, first-in-class, dual GIP/GLP-1 receptor agonist.
Academic Article Comparison of the Usability, Accuracy, Preference, and Satisfaction of Three Once-Weekly Glucagon-Like Peptide 1 Receptor Agonist Pen Devices in People With Type 2 Diabetes.

Search Criteria
  • Glucagon Like Peptide 1 Receptor

Copyright © 2023 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)